
|Videos|February 9, 2022
Potential Changes for MRD in the Future
Kashyap Patel, MD, and Jason Starr, DO, explain the potential changes providers might see in the future for MRD.
Advertisement
Episodes in this series
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
3
ACO-SWITCH to Evaluate Tafamidis-to-Acoramidis Switch in ATTR-CM
4
FAQ: Prior Authorization Reform—Will Changes Go Far Enough by 2027?
5






